Login to Your Account



NeuroSearch Getting €32M from Janssen in Early Stage CNS Deal

By Jennifer Boggs


Tuesday, August 18, 2009

In its second major collaboration this year, Danish biotech NeuroSearch A/S inked a discovery deal with Johnson & Johnson unit Janssen Pharmaceutica NV for central nervous system disease drugs, a move that strengthens the company's balance sheet ahead of expected data from its late-stage Huntington's disease program. (BioWorld Today)

 

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription